Glioma is a metabolically affected disease due to IDH mutation (Dang et al., 2009), and LGG shows the broadest survival correlation with metabolic disorders compared to other tumors (Vander Heiden and DeBerardinis, 2017). The gene discussed is IDH1; the disease is metabolic disease.